Novel Therapies for Aggressive B-Cell Lymphoma
Aggressive B-cell lymphoma (BCL) comprises a heterogeneous group of malignancies, including diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma, and mantle cell lymphoma (MCL). DLBCL, with its 3 subtypes, is the most common type of lymphoma. Advances in chemoimmunotherapy have substantially impr...
Saved in:
Main Authors: | Kenneth A. Foon, Kenichi Takeshita, Pier L. Zinzani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2012/302570 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microenvironment-Centred Dynamics in Aggressive B-Cell Lymphomas
by: Matilde Cacciatore, et al.
Published: (2012-01-01) -
Efficacy and Safety of CART Cell Therapy in Aggressive B‐Cell Lymphomas Involving the Gastrointestinal Tract
by: Lixia Ma, et al.
Published: (2025-01-01) -
Aggressive large B cell lymphoma mimicking turban tumor
by: Ashish Singh, et al.
Published: (2023-07-01) -
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
by: Gohar S. Manzar, et al.
Published: (2025-01-01) -
Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry
by: Frederick L Locke, et al.
Published: (2025-02-01)